Greenland Mines Ltd (GRML) stock
GRMLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as GRMLW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/30
$2.99+0.08 (+2.75%)
Close on Nov 20, 2026Market cap $40.92MP/E –Yield –
Greenland Mines r&d expenses
Research and development expenses are spending on new products and technology.
Greenland Mines's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.26M, up 145.2% year over year. For fiscal 2025 it was $634.19K.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $634.19K | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $409.52K | +49.8% |
| Q2 FY2026 | Jun 30, 2026 | $400.54K | +67.8% |
| Q1 FY2026 | Mar 31, 2026 | $321.27K | – |
| Q4 FY2025 | Dec 31, 2025 | $124.34K | – |
| Q3 FY2025 | Sep 30, 2025 | $273.31K | – |
| Q2 FY2025 | Jun 30, 2025 | $238.70K | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
See a number that looks wrong?